0001171843-18-006601.txt : 20180918 0001171843-18-006601.hdr.sgml : 20180918 20180918144825 ACCESSION NUMBER: 0001171843-18-006601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180914 FILED AS OF DATE: 20180918 DATE AS OF CHANGE: 20180918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENBERG MORRIS CENTRAL INDEX KEY: 0001202786 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 181075459 MAIL ADDRESS: STREET 1: C/O SAETTLE GENETICS INC STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 ownership.xml X0306 4 2018-09-14 0 0000722830 IMMUNOMEDICS INC IMMU 0001202786 ROSENBERG MORRIS C/O IMMUNOMEDICS, INC 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 0 1 0 0 Chief Technology Officer Stock Options (right to buy) 22.27 2018-09-14 4 A 0 37300 0.0 A 2019-09-14 2025-09-14 Common Stock, par value $0.01 per share 37300 37300 D The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and on a quarterly basis thereafter over a three year period. /s/ Morris Rosenberg 2018-09-18